Advertisement

Topics

Raynaud's Syndrome - Biotech, Pharma and Life Science Channel

21:54 EDT 21st August 2017 | BioPortfolio

PubMed Articles [4964 Associated PubMed Articles listed on BioPortfolio]

Extracorporeal CO2 removal by hemodialysis: in vitro model and feasibility.

Critically ill patients with acute respiratory distress syndrome and acute exacerbations of chronic obstructive pulmonary disease often develop hypercapnia and require mechanical ventilation. Extracor...

Human perinatal immunity in physiological conditions and during infection.

The intrauterine environment was long considered sterile. However, several infectious threats are already present during fetal life. This review focuses on the postnatal immunological consequences of ...

Systematic review and meta-analysis of complications and mortality of veno-venous extracorporeal membrane oxygenation for refractory acute respiratory distress syndrome.

Veno-venous extracorporeal membrane oxygenation (ECMO) for refractory acute respiratory distress syndrome (ARDS) is a rapidly expanding technique. We performed a systematic review and meta-analysis of...

Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: a prospective descriptive study.

Despite few studies, a monitoring of a neuromuscular blockade with a train of four (TOF) is recommended in intensive care unit (ICU). Our objective was to compare the results of ulnar and facial TOF m...

Degradation and inactivation of Shiga toxins by nitrogen gas plasma.

Shiga toxin (Stx)-producing Escherichia coli (STEC) leads to food poisoning by causing hemorrhagic colitis and hemolytic uremic syndrome. Some STEC produce Shiga toxin 1 (Stx1) and/or Shiga toxin 2 (S...

Can glypican-3 be a disease-specific biomarker?

Glypican-3 (GPC3) is a cell surface-bound proteoglycan which has been identified as a potential biomarker candidate in hepatocellular carcinoma, lung carcinoma, severe pneumonia, and acute respiratory...

The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.

The purpose of the study is to evaluate the efficiency and safety of tacrolimus (TAC) monotherapy in the treatment of nephrotic idiopathic membranous nephropathy (IMN) compared with the protocol of cy...

The reversible P2Y12 antagonist ACT-246475 causes significantly less blood loss than ticagrelor at equivalent antithrombotic efficacy in rat.

The P2Y12 receptor is a validated target for prevention of major adverse cardiovascular events in patients with acute coronary syndrome. The aim of this study was to compare two direct-acting, reversi...

The Prevalence of Cyclospora cayetanensis and Cryptosporidium spp. in Turkish patients infected with HIV-1.

Opportunistic infections such as cryptosporidiosis and cyclosporiasis are commonly encountered in patients with acquired immunodeficiency syndrome (AIDS). We investigated the existence of opportunisti...

Vitamin D Deficiency, Supplementation, and Cardiovascular Health.

Vitamin D has been traditionally recognized as a vitamin quintessential for bone-mineral health. In the past 2 decades, numerous experimental and observational studies have highlighted the role of vit...

News Articles [1291 Associated News Articles listed on BioPortfolio]

Short Bowel Syndrome Epidemiology Insights to 2025 [Report Updated: 31072017] Prices from USD $2950

DelveInsight's Short Bowel Syndrome Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Short Bowel Syndrome in seven major markets US, France, Germany, Italy, Spain, UK and...

The Disturbing, Eugenics-Like Reality Unfolding in Iceland

(Quartz) – Here’s the interesting thing: Down syndrome, or Trisomy 21 as it is also called, is actually one of the less severe chromosomal conditions. Unlike many other trisomies (genetic cond...

ClearFlow, Inc. Announces Positive US Clinical Trial Results

Reduction of Hospital Complications and Resource Utilization after Heart Surgery Demonstrated with Use of the PleuraFlow® ACT® System ClearFlow, Inc., a medical devic...

Caret Pharma grows footprint with Fiber Choice acquisition

Fiber Choice will join a growing digestive health product portfolio that already includes IBgard (for irritable bowel syndrome) and FDgard (for functional dyspepsia). read more

Down Syndrome Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1250

DelveInsight's, Down Syndrome Pipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this Down Syndrome. The key objective of the report is to establish the under...

‘Safer’ Down’s syndrome test to be introduced in Wales – BBC News

BBC News'Safer' Down's syndrome test to be introduced in WalesBBC NewsA safer and more accurate test for Down's syndrome is to be introduced for pregnant mothers in Wales, the Welsh Government has ann...

Pilot study to evaluate cell therapy as treatment for acute radiation syndrome

A pilot study using nonhuman primates as subjects will be launched by the Armed Forces Radiobiology Research Institute of the -More- 

Gamida Cell Announces First Patient Transplanted in Phase 1/2 Study of CordIn for Severe Aplastic Anemia and Hypoplastic MDS

JERUSALEM, Aug.  21, 2017 /PRNewswire/ -- The first subject has been transplanted in an investigator-initiated study of Cordin™ for patients with severe aplastic anemia (AA) or hypoplastic...

No, a Vaccine Court ruling does not show that vaccines cause SIDS

There was a rumbling in the antivaccine underground over the weekend about a recent ruling by the Vaccine Court compensating parents of a child who died of sudden infant death syndrome (SIDS). In a co...

Caret Pharma To Acquire Fiber Choice®

BOCA RATON, Fla., Aug. 21, 2017 /PRNewswire/ -- Caret Pharma, a subsidiary of Caret Group, today announced it has entered into an agreement with Moberg Pharma AB to acquire the assets of Fiber Ch...

Events [0 Results]

None

Companies [62 Associated Companies listed on BioPortfolio]

Agilis Biotherapeutics and GTRI

Agilis is advancing innovative gene therapies designed to provide long-term efficacy for patients with debilitating, often fatal, rare genetic diseases that affect the central ner...

PAVmed Inc.

PAVmed Inc. (Nasdaq: PAVM, PAVMW) is a highly differentiated, multi-product medical device company employing a unique business model designed to advance products from concept to c...

Agilis Biotherapeutics, Inc.

Agilis is advancing innovative gene therapies designed to provide long-term efficacy for patients with debilitating, often fatal, rare genetic diseases that affect the central ner...

Ironwood Pharmaceuticals, Inc. 

Ironwood Pharmaceuticals (NASDAQ:IRWD) is a commercial biotechnology company focused on creating medicines that make a difference for patients, building value for our fellow share...

Mati Therapeutics, Inc.

Mati is developing the Evolute® sustained ocular drug delivery platform, which Mati believes has the potential to treat a range of ocular indications. The platform utilizes a d...

MedAutonomic

MedAutonomic is a privately held medtech company dedicated to developing a bioelectric medicine to treat patients with functional diseases of the metabolic syndrome such as type-2...

Ironwood Pharmaceuticals, Inc. & Astellas Pharma Inc.

Ironwood Pharmaceuticals (NASDAQ: IRWD) is a commercial biotechnology company focused on creating medicines that make a difference for patients, building value for our fellow shar...

XenoPort

We are a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates for the potential treatment of central nervous system (CNS) disorders. We also have a p...

Velicept Therapeutics, Inc.

Velicept Therapeutics, Inc. is a privately held, clinical development company focused on advancing best-in-class compounds with the potential to fill unmet medical needs. Its lead...

Alexion Pharmaceuticals Inc.

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed ...

Clinical Trials [3204 Associated Clinical Trials listed on BioPortfolio]

Turmeric as Treatment in Epilepsy

This is a single center open-label pilot clinical trial of patients 1-70 years of age with greater than 6 seizures per month diagnosed with Dravet Syndrome, Lennox-Gastaut Syndrome, Tubero...

Duration of Dual Anti-Platelet Therapy (DUAL-ACS2)

Despite substantial evidence supporting the use of dual anti-platelet therapy in patients with acute coronary syndrome, there remains major uncertainty regarding the optimal duration of th...

Alterations of Attention in POTS Depending on Body Position and Hydration

The Postural Tachycardia-Syndrome (POTS) is a form of autonomic dysregulation, typically accompanied by symptoms of orthostatic intolerance (OI). OI is defined by the inability to tolerate...

Berberine Treat MetS in Schizophrenia

In early clinical study investigators confirmed that berberine could prevent glucose and lipid metabolism disorder in schizophrenia, so investigators intend to verify the effect and safety...

Multi-strain Probiotic in the Management of IBS-D

1. To assess the effect of multistrain probiotics on abdominal pain using a validated symptom severity score in IBS patients. 2. To assess the efficacy of a multi-strain probiotic ...

Mirabegron for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing

The aim of this study is to elucidate whether night-time dosing of mirebegron can improve nocturia, compared with daytime dosing of mirabegron.

Use of PRP in Endometrial Reconstruction

Infertility, which affected 48.5 million couples worldwide in 2010 alone, has many causes; some causes result from issues related to the endometrium. Unfortunately, no cure exists for medi...

sPLA2 in EBC During Acute Chest Syndrome

Secretory phosholipases A2 (sPLA2) are significantly elevated in the plasma of sickle cell disease patients with acute chest syndrome, and similar enzymes have been measured in exhaled bre...

Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)

The purpose of this study is to determine if the use of image-guided, endovascular therapy (EVT) is an effective strategy with which to reduce Post Thrombotic Syndrome (PTS) disease severi...

Treatment of RLS/WED Symptoms Through Sensory Counter-stimulation

To evaluate, in a pilot fashion, efficacy and tolerability of electrical counter-stimulation using the Scrambler device in alleviating uncomfortable sensations and urge to move in patients...

Videos

None available.

Medical and Biotech [MESH] Definitions

An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.

A mild form of LIMITED SCLERODERMA, a multi-system disorder. Its features include symptoms of CALCINOSIS; RAYNAUD DISEASE; ESOPHAGEAL MOTILITY DISORDERS; sclerodactyly, and TELANGIECTASIS. When the defect in esophageal function is not prominent, it is known as CRST syndrome.

A selective adrenergic alpha-1 antagonist used in the treatment of heart failure, hypertension, pheochromocytoma, Raynaud's syndrome, prostatic hypertrophy, and urinary retention.

A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.

A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a "speckled" epidermal nuclear staining pattern on direct immunofluorescence.

Quick Search
Advertisement
 
review and buy Raynaud's Syndrome market research data and corporate reports here

Channels Quicklinks